Edition:
India

Health Headlines

KemPharm's opioid painkiller gets FDA approval, shares soar

KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain, sending the shares of the drugmaker up as much as 36 percent in late afternoon trading.

Japan wins WTO dispute over Fukushima-related food

The World Trade Organization largely upheld a Japanese complaint against South Korean import bans and additional testing requirements imposed on Japanese seafood because of the 2011 Fukushima nuclear disaster.

//